{"schema_version":"1","generated_at":"2026-11-15T23:49:14.236Z","data_as_of":null,"url":"https://www.findmykol.com/kol/trevor-jolly","json_url":"https://www.findmykol.com/kol/trevor-jolly/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"trevor-jolly","name":"Trevor Jolly","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"University of North Carolina at Chapel Hill","institution_url":"https://www.findmykol.com/institution/university-of-north-carolina-at-chapel-hill","city":"Lumberton","state":"NC","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1588893218","orcid":"0000-0003-2900-848X","openalex":"A5001873996"},"summary":"Trevor Jolly is an Oncology physician affiliated with University of North Carolina at Chapel Hill. OpenAlex indexes 58 publications with 1,488 citations (h-index 19); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":58,"cited_by_count":1488,"h_index":19,"latest_activity_year":2025,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT03951090","title":"Geriatric Assessment Reporting in Real Time (GARRT) in Non-electively Hospitalized Older Cancer Patients","phase":"NA","status":"COMPLETED","role":"Overall official","sponsor":"UNC Lineberger Comprehensive Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT03951090","trial_url":"https://www.findmykol.com/trial/NCT03951090"}],"source":"trials"},"payments":{"company_count":7,"program_years":{"first":2021,"last":null},"rows_total":12,"shown":3,"withheld":9,"rows":[{"payer":"Janssen Biotech, Inc.","program_year":2025,"amount_usd":58.15,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1588893218"},{"payer":"Merck Sharp & Dohme LLC","program_year":2025,"amount_usd":32.32,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1588893218"},{"payer":"PUMA BIOTECHNOLOGY, INC.","program_year":2025,"amount_usd":23.34,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1588893218"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1588893218","source":"payments"},"prescribing":{"data_year":2024,"areas_total":1,"areas_shown":1,"areas":[{"area":"Cancer & immunology","share_pct":100,"classes_total":1,"classes":[{"class":"Aromatase Inhibitor","setting":"prescribed","share_pct":100,"drugs":[{"name":"Anastrozole","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":100,"facility_pct":0},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Correction to: Measuring and understanding adherence in a home-based exercise intervention during chemotherapy for early breast cancer","year":2025,"journal":"Carolina Digital Repository (University of North Carolina at Chapel Hill)","source_url":"https://doi.org/10.17615/3hj3-ka91","status":"verified"},{"title":"Quality of Life Outcomes in Breast Cancer Patients Receiving Chemotherapy With or Without Radiation Therapy","year":2024,"journal":"Clinical Breast Cancer","source_url":"https://doi.org/10.1016/j.clbc.2024.08.015","status":"verified"},{"title":"Abstract GS3-06: GS3-06 Palbociclib After CDK4/6i and Endocrine Therapy (PACE): A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab for Endocrine Pre-treated ER+/HER2- Metastatic Breast Cancer","year":2023,"journal":"Cancer Research","source_url":"https://doi.org/10.1158/1538-7445.sabcs22-gs3-06","status":"verified"},{"title":"A phase II single‐arm trial of memantine for prevention of cognitive decline during chemotherapy in patients with early breast cancer: Feasibility, tolerability, acceptability, and preliminary effects","year":2023,"journal":"Cancer Medicine","source_url":"https://doi.org/10.1002/cam4.5619","status":"verified"},{"title":"Circulating tumor cells (CTCs) dynamics after CDK4/6i for hormone-receptor positive (HR+) metastatic breast cancer (MBC): A biomarker analysis of the PACE randomized phase II study.","year":2023,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2023.41.16_suppl.1059","status":"verified"}],"source":"works"},"contact":{"address_1":"1200 PINE RUN DR","city":"Lumberton","state":"NC","zip":"283582180","phone":"910-671-5730","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1588893218","source":"identity"},"similar":[{"name":"Diana Perkins","slug":"diana-perkins","institution":"University of North Carolina at Chapel Hill","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/diana-perkins","json_url":"https://www.findmykol.com/kol/diana-perkins/profile.json"},{"name":"Douglas Drossman","slug":"douglas-drossman","institution":"University of North Carolina at Chapel Hill","specialty":"Gastroenterology","url":"https://www.findmykol.com/kol/douglas-drossman","json_url":"https://www.findmykol.com/kol/douglas-drossman/profile.json"},{"name":"Michael Knowles","slug":"michael-knowles","institution":"University of North Carolina at Chapel Hill","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/michael-knowles","json_url":"https://www.findmykol.com/kol/michael-knowles/profile.json"},{"name":"David Margolis","slug":"david-margolis","institution":"University of North Carolina at Chapel Hill","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/david-margolis","json_url":"https://www.findmykol.com/kol/david-margolis/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Stuart Orkin","slug":"stuart-orkin","institution":"Harvard Medical School","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/stuart-orkin","json_url":"https://www.findmykol.com/kol/stuart-orkin/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":9,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2025-09-02","provider_certified":"2025-09-02","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}